Intel®, Cancer Research UK and Imperial College London Celebrate Supercomputing Successes in the UK

IntelToday Cancer Research UK and Imperial College London outlined the fundamental importance of High Performance Computing to their future science and research strategies. The two organisations described how Intel® High Performance Computing (HPC) solutions are enabling them to drive forward their research, which will lead to future scientific breakthroughs.

Imperial College London currently spends over £1,000 000 on its HPC programme. "HPC allows us to simulate events that would be impossible or very difficult to measure experimentally," stated Simon Burbidge, High Performance Computing Co-ordination Manager at Imperial College London. "For example, it is very difficult to reach the kind of temperatures such as those within the sun or plasmas in the real world, but by using HPC we can perform simulations to predict the results and thus tune the experiments. Another area of research at Imperial College London is using HPC to model blood flows in human arteries, to drive insights into the conditions leading to heart and circulatory disease. It is also helping us to do better research at lower cost, for example where simulations can replace some of the wind tunnel tests used in automobile design."

Peter McCallum, Head of IT & Scientific Computing at Cancer Research UK's Cambridge Research Institute described the benefits that HPC has brought to his organisation, "Through HPC we can effectively sequence a human’s whole DNA. Medical units in hospitals may soon need HPC access to enable them to track disease. We believe that in the future there will be local access to HPC with a local scientific computing team in all biological science organisations. What happened in physics and chemistry twenty years ago is now happening in biology."

Sean McGuire, Director Strategic Government Programs HPC EMEA at Intel stated, "HPC is an added direction for Intel. Through the Intel® Many Integrated Core (MIC) architecture we can achieve more compute power than would have been possible previously. It is an architecture that is designed for highly parallel workloads. We believe that it is an indication of where computing is going."

Robert Maskell, Head of HPC for Intel in the UK added, "Analysts have been telling us for a while that HPC is now mainstream, I think it is even further along the curve than that. It is pervasive. It is difficult to think of any manmade object which has not been created without being touched by HPC during the design process. HPC has become one of the fundamental building blocks for science. Researchers are being deluged by floods of data. The question they are asking is how can they cost effectively process and securely store that data. We believe Intel's Xeon range of processors deliver the energy-efficient performance that will allow researchers to draw ever quicker results and conclusions from their science."

Intel Corporation announced plans earlier this year to deliver new products based on the Intel® Many Integrated Core (MIC) architecture that will create platforms running at trillions of calculations per second, while also retaining the benefits of standard Intel processors. Targeting high-performance computing segments such as exploration, scientific research and financial or climate simulation, the first product, codenamed "Knights Corner", will be made on Intel's 22-nanometer manufacturing (nm) process - using transistor structures as small as 22 billionths of a meter - and will use Moore's Law to scale to more than 50 Intel processing cores on a single chip. While the vast majority of workloads will still run best on award-winning Intel® Xeon® processors, Intel® MIC architecture will help accelerate select highly parallel applications.

Industry design and development kits codenamed "Knights Ferry" are currently shipping to select developers, and beginning in the second half of 2010, Intel will expand the program to deliver an extensive range of developer tools for Intel MIC architecture.

Related news articles:

About Intel
Intel (NASDAQ: INTC), the world leader in silicon innovation, develops technologies, products and initiatives to continually advance how people work and live. Additional information about Intel is available at www.intel.com/pressroom and blogs.intel.com.

Most Popular Now

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

AI Spots Hidden Signs of Depression in S…

Depression is one of the most common mental health challenges, but its early signs are often overlooked. It is often linked to reduced facial expressivity. However, whether mild depression or...

AI Model Forecasts Disease Risk Decades …

Imagine a future where your medical history could help predict what health conditions you might face in the next two decades. Researchers have developed a generative AI model that uses...

AI Tools Help Predict Severe Asthma Risk…

Mayo Clinic researchers have developed artificial intelligence (AI) tools that help identify which children with asthma face the highest risk of serious asthma exacerbation and acute respiratory infections. The study...

AI Model Indicates Four out of Ten Breas…

A project at Lund University in Sweden has trained an AI model to identify breast cancer patients who could be spared from axillary surgery. The model analyses previously unutilised information...

Smart Device Uses AI and Bioelectronics …

As a wound heals, it goes through several stages: clotting to stop bleeding, immune system response, scabbing, and scarring. A wearable device called "a-Heal," designed by engineers at the University...

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

ChatGPT 4o Therapeutic Chatbot 'Ama…

One of the first randomized controlled trials assessing the effectiveness of a large language model (LLM) chatbot 'Amanda' for relationship support shows that a single session of chatbot therapy...

Overcoming the AI Applicability Crisis a…

Opinion Article by Harry Lykostratis, Chief Executive, Open Medical. The government’s 10 Year Health Plan makes a lot of the potential of AI-software to support clinical decision making, improve productivity, and...

Dartford and Gravesham Implements Clinis…

Dartford and Gravesham NHS Trust has taken a significant step towards a more digital future by rolling out electronic test ordering using Clinisys ICE. The trust deployed the order communications...